Target intelligence / Profile preview

Ultraviolet B and Ultraviolet A radiation (UVB/UVA)

Target
UVB/UVA
Molecular classification
Other
01

Overview

Ultraviolet B (UVB) and Ultraviolet A (UVA) radiation are segments of the electromagnetic spectrum emitted by the sun and artificial sources that significantly impact human health (WHO, 2023). UVB (280–315 nm) is the primary cause of direct DNA damage, leading to the formation of cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts, which are precursors to skin cancer (IARC, 2012). UVA (315–400 nm) penetrates deeper into the dermis, where it generates reactive oxygen species (ROS) that cause indirect oxidative damage to DNA and structural proteins like collagen, driving the process of photoaging (PubMed, PMID: 18248499). While these are physical agents rather than biological molecules or receptors, they are the primary targets for photoprotective agents such as sunscreens. Sunscreens, including physical blockers like Zinc oxide and chemical absorbers like Avobenzone, work by reflecting or absorbing these photons to prevent their interaction with cellular chromophores (FDA, 2021). Additionally, UV radiation is utilized therapeutically in controlled doses for treating dermatological conditions like psoriasis and vitiligo, though chronic exposure remains a major risk factor for melanoma and keratinocyte carcinomas (Skin Cancer Foundation, 2022).

Other names
UV radiationSolar radiationActinic radiationUltraviolet light
02

Mechanism of action

Physical or chemical absorption, reflection, or scattering of ultraviolet photons to prevent their penetration into the skin and subsequent interaction with biological chromophores such as DNA (FDA, 2021).

03

Biological functions

Vitamin D synthesisDNA damage inductionMelanogenesisPhoto-immunomodulationReactive oxygen species generation
04

Disease associations

Skin cancer (Melanoma, Basal cell carcinoma, Squamous cell carcinoma)Erythema (Sunburn)PhotoagingCataractPhotodermatoses
05

Safety considerations

CarcinogenicityMutagenicityPhoto-sensitizationImmunosuppressionAccelerated skin aging
06

Interacting drugs

Zinc oxide

7 more in the full profile.

07

Biomarkers

Cyclobutane pyrimidine dimers (CPDs)6-4 photoproductsMinimal Erythema Dose (MED)8-oxo-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Ultraviolet B and Ultraviolet A radiation (UVB/UVA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultraviolet B and Ultraviolet A radiation (UVB/UVA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call